Ordnc 2024 000022 U24230Tg2022Ptc166870 Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 2 Year, 4 Months
About Ordnc 2024 000022 U24230Tg2022Ptc166870
Ordnc 2024 000022 U24230tg2022ptc166870 Private Limited (O20UPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 2022 (Two years and four months 11 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Palanki Rani and Sai Palanki serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24230TG2022PTC166870
- Company No.
166870
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2022
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Ordnc 2024 000022 U24230Tg2022Ptc166870?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sai Palanki  | Managing Director | 20-Sep-2022 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Palanki Rani | Director | 20-Sep-2022 | Current |
Financial Performance of Ordnc 2024 000022 U24230Tg2022Ptc166870.
Enhance accessibility to Ordnc 2024 000022 U24230Tg2022Ptc166870's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ordnc 2024 000022 U24230Tg2022Ptc166870?
Unlock access to Ordnc 2024 000022 U24230Tg2022Ptc166870's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sterline Bio Remedies Private LimitedPalanki Rani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ordnc 2024 000022 U24230Tg2022Ptc166870?
Ordnc 2024 000022 U24230Tg2022Ptc166870 has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ordnc 2024 000022 U24230Tg2022Ptc166870, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ordnc 2024 000022 U24230Tg2022Ptc166870's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.